Class of 2025
For pioneering research elucidating the tumor suppressive functions of the hereditary breast cancer gene BRCA2 in genome maintenance, uncovering the mechanisms responsible for carcinogenesis in BRCA2 mutation carriers, and advancing technologies to accelerate drug discovery, thereby establishing a foundation for the development of novel cancer therapies.
*Full-length biography in development
[Institutional affiliations listed for Fellows reflect those held at the time of their induction into the AACR Academy.]